Methods of induction of labour

Current Opinion in Obstetrics and Gynecology

Volumn 9, Issue 6, 1997, Pages 375-378

  Refaey, Hazem El ^a   Jauniaux, Eric ^a  

^a UNIVERSITY COLLEGE HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

MISOPROSTOL; OXYTOCIN; PROSTAGLANDIN E2; PROSTAGLANDIN F2 ALPHA;

DRUG ABSORPTION; DRUG EFFECT; DRUG EFFICACY; DRUG HALF LIFE; DRUG POTENCY; GASTROINTESTINAL TOXICITY; HUMAN; LABOR INDUCTION; PRIORITY JOURNAL; REVIEW; UTERUS CONTRACTILITY; UTERUS CONTRACTION;

EID: 0030689790     PISSN: 1040872X     EISSN: None     Source Type: Journal    
DOI: 10.1097/00001703-199712000-00008     Document Type: Review

References (21)

1. Kelly RW, Cheng L, Thong J, Yong EL, Baird DT: Synthesis and metabolism of uterine prostaglandins. In Prostaglandins and the Uterus. Edited by Drife JO, Calder AA. London: Springer-Verlag; 1991:3-15.
2. Karim SMM, Trussell RR, Patel RC, Millier K: Response of pregnant human uterus to prostaglandin-F2α-induction of labour. BMJ 1968, iv:621-623.
3. Karim SMM, Filshie GM: Therapeutic abortion using prostaglandin F2α. Lancet 1970, 1:157-159.
4. Bundy G, Lincoln F, Nelson N, Pike J, Schneider W: Novel prostaglandin syntheses. Ann N Y Acad Sci 1971, 180:76-90.
5. Karim SMM, Sharma DD: Termination of second trimester pregnancy with 15-methyl analogues of prostaglandin E2 and F2α. J Obstet Gynaecol (Br Commonwealth) 1972, 79:737-743.
6. Robert A, Nezamis JE, Phillips JP: Inhibition of gastric secretion by prostaglandins. Am J Digest Dis 1967, 12:1073.
7. Kararli TT, Catalano T, Needham TE, Finnegan PM: Mechanism of misoprostol stabilization in hydroxypropyl methylcellulose. Adv Exp Med Biol 1991, 302:275-289.
8. Collins PW: Misoprostol: discovery, development, and clinical applications. Med Res Rev 1990, 10:149-172.
9. Schonhofer PS: Brazil: misuse of misoprostol as an abortifacient may induce malformations. Lancet 1991, 337:1534-1535.
10. Costa SH, Vessey MP: Misoprostol and illegal abortion in Rio de Janeiro, Brazil. Lancet 1993, 341:1258-1261.
11. Aubeny E, Baulieu EE: Activite contragestivie de l'association au RU486 d'une prostaglandine active par voie'oral [in French]. C R Acad Sci (III) 1991, 312:539-546.
12. Marguilies M, Perez MC, Vato L: Misoprostol to induce labour. Lancet 1992, 339:64.
13. Fletcher H, Mitchell S, Frederick J, Simeon D, Brown D: Intravaginal misoprostol versus dinoprostone as cervical ripening and labour inducing agents. Obstet Gynecol 1994, 83:244-247.
14. Sanchez-Ramos L, Kaunitz AM, Dell Valle GO, Delke I, Schroeder PA, Briones DK: Labour induction with prostaglandin E1 methyl analogue misoprostol versus oxytocin: a randomised trial. Obstet Gynecol 1993, 81:332-336.
15. Fletcher HM, Mitchell S, Simeon D, Frederick J, Brown D: Intravaginal misoprostol as a cervical ripening agent. Br J Obstet Gynaecol 1993, 100:641-644.
16. Sanchez-Ramos L, Kauntiz A, Wears R, Delke I, Gauder F: Misoprostol for cervical ripening and labour induction: a meta analysis. Obstet Gynecol 1997, 89:633-642.
17. Wing D, Rahal A, Jones M, Goodwin M, Paul R: Misoprostol: an effective agent for cervical ripening and labour induction. Am J Obstet Gynecol 1995, 172:1811-1816.
18. Wing D, Rahal A, Jones M, Goodwin M, Paul R: A comparison of misoprostol and prostaglandin E2 gel for preinduction cervical and labour induction. Am J Obstet Gynecol 1995, 172:1804-1810.
19. Wing D, Paul RA: Misoprostol for induction of labour. Am J Obstet Gynecol 1997, 174:797.
20. Karim A: Antiulcer prostaglandin misoprostol: single and multiple dose pharmacokinetic profile. Prostaglandins 1987, (suppl):40-50.
21. Zeiman M, Fong S, Benowitz N, Bansketer D, Darney P: Absorption kinetics of misoprostol with oral and vaginal administration. Obstet Gynecol 1997, 90:88-92.